title: RGD-containing peptides induce endothelium-dependent and independent vasorelaxations of rat aortic rings.
abstract: Peptides containing the extracellular matrix peptide cell attachment sequence RGD possess potent, endothelium-dependent vasorelaxant properties. In the present study, the ability of RGD-containing peptides to cause vasorelaxation in the presence and absence of a functional endothelium was examined in rat aortic rings along with the ability of RGD-containing peptides to increase cGMP production in these vessels. The active RGD-containing peptide GRGDNP induced rapid relaxation in endothelium-intact, norepinephrine contracted rat aortic rings. When the endothelium was removed, RGD-containing peptides produced a slow relaxation of contracted rings which took approx. 40 min to reach maximum relaxation. Control RGD peptides were without effect either in the presence or absence of a functional endothelium. While acetylcholine and sodium nitroprusside stimulated cGMP production in endothelium-intact and denuded aortic segments, neither the control RGD peptide nor the active GRGDNP increased cGMP in these vessels when compared to controls upon either short (30 s) or long (45 min) incubation times. These data indicate that relaxations of rat aortic rings in response to RGD-containing peptides occur both in the presence and absence of an intact endothelium and that cGMP is likely not the sole mediator of these responses.
authors.affiliation: Division of Pharmacology and Experimental Therapeutics, College of Pharmacy, University of Kentucky, Lexington 40536-0082, USA.
authors.forename: D W
authors.initials: DW
authors.lastname: Lipke
authors.forename: E E
authors.initials: EE
authors.lastname: Soltis
authors.forename: R R
authors.initials: RR
authors.lastname: Fiscus
authors.forename: L
authors.initials: L
authors.lastname: Yang
authors.forename: P S
authors.initials: PS
authors.lastname: Newman
authors.forename: S M
authors.initials: SM
authors.lastname: Aziz
mesh_terms: D000109:Acetylcholine / Q000494:pharmacology; D000595:Amino Acid Sequence; D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects / Q000502:physiology; D006152:Cyclic GMP / Q000096:biosynthesis* / Q000276:immunology; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000502:physiology; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000187:drug effects* / Q000502:physiology; D009599:Nitroprusside / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D009842:Oligopeptides / Q000494:pharmacology*; D011863:Radioimmunoassay; D051381:Rats; D017207:Rats, Sprague-Dawley; D013997:Time Factors; D014664:Vasodilation / Q000187:drug effects*; D014665:Vasodilator Agents / Q000494:pharmacology
chemical_list: D009842:Oligopeptides; D014665:Vasodilator Agents; C103774:glycyl-arginyl-glycyl-aspartyl-asparaginyl-proline; D009599:Nitroprusside; C047981:arginyl-glycyl-aspartic acid; D006152:Cyclic GMP; D000109:Acetylcholine; D009638:Norepinephrine